{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2373815",
  "DateCompleted": {
    "Year": "1990",
    "Month": "08",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "07",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0735-1097",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "2",
        "PubDate": {
          "Year": "1990",
          "Month": "Aug"
        }
      },
      "Title": "Journal of the American College of Cardiology",
      "ISOAbbreviation": "J Am Coll Cardiol"
    },
    "ArticleTitle": "Increased intracardiovascular clotting in patients with chronic atrial fibrillation.",
    "Pagination": {
      "StartPage": "377",
      "EndPage": "380",
      "MedlinePgn": "377-80"
    },
    "Abstract": {
      "AbstractText": [
        "To clarify whether the formation of thrombi could be induced by atrial fibrillation itself or by factors predisposing to atrial fibrillation such as mitral stenosis, plasma D-dimer levels (cross-linked fibrin degradation products) were measured in 73 patients without atrial fibrillation (Group 2). In Group 1, 49 of the 73 patients had factors predisposing to atrial fibrillation such as valvular heart disease, and the remaining 24 had lone atrial fibrillation. In Group 2, 16 patients had organic heart disease and the remaining 5 had a chest pain syndrome. The plasma D-dimer level was significantly higher in Group 1 (150 +/- 19 ng/ml) than in Group 2 (61 +/- 3 ng/ml) (p less than 0.01, mean +/- standard error of the mean). In both groups, there were no significant differences in plasma D-dimer level between patients with and without organic heart disease (146 +/- 18 versus 156 +/- 46 ng/ml in Group 1; 61 +/- 4 versus 59 +/- 10 ng/ml in Group 2). These findings indicate that atrial fibrillation itself may be more important than factors predisposing to atrial fibrillation in the development of intracardiovascular clotting."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Cardiology, Osaka Prefectural Hospital, Japan."
          }
        ],
        "LastName": "Kumagai",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fukunami",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ohmori",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kitabatake",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kamada",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hoki",
        "ForeName": "N",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Am Coll Cardiol",
    "NlmUniqueID": "8301365",
    "ISSNLinking": "0735-1097"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Fibrin Fibrinogen Degradation Products"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "fibrin fragment D"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood",
        "complications"
      ],
      "DescriptorName": "Atrial Fibrillation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chronic Disease"
    },
    {
      "QualifierName": [
        "etiology"
      ],
      "DescriptorName": "Embolism"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Fibrin Fibrinogen Degradation Products"
    },
    {
      "QualifierName": [
        "blood",
        "etiology"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "blood",
        "etiology"
      ],
      "DescriptorName": "Thrombosis"
    }
  ]
}